NEJM: Urologist self-referral equals IMRT overuse
Allowing urologists to self-refer patients for intensity-modulated radiation (more) (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 24, 2013 Category: Radiology Source Type: news

NEJM study exposes overuse of radiation therapy when urologists profit from self-referral
(American Society for Radiation Oncology) A comprehensive review of Medicare claims for more than 45,000 patients from 2005 through 2010 found that nearly all of the 146 percent increase in intensity- modulated radiation therapy for prostate cancer among urologists with an ownership interest in the treatment was due to self-referral, according to new research, "Urologists' Use of Intensity- Modulated Radiation Therapy for Prostate Cancer," released today in The New England Journal of Medicine for its October 24, 2013 issue. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 23, 2013 Category: Global & Universal Source Type: news

Advanced form of proton therapy reduces need for feeding tubes by 50 percent
A new study from researchers at The University of Texas MD Anderson Proton Therapy Center found that the use of feeding tubes in oropharyngeal carcinoma (OPC) cancer patients treated with intensity modulated proton therapy (IMPT) decreased by more than 50 percent compared to patients treated with intensity modulated radiation therapy (IMRT). This suggests that proton therapy may offer vital quality of life benefits for patients with tumors occurring at the back of the throat. The results, presented by the lead researcher, Steven J. Frank, M.D... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 29, 2013 Category: Consumer Health News Tags: Ear, Nose and Throat Source Type: news

Department of Health earmarks another £30m for cancer
The machines are capable of delivering both standard radiotherapy and intensity modulated radiation therapy (IMRT), which is a particularly important form of treatment for head and neck cancers because it can be used to target the tumour more precisely, meaning there are fewer side-effects for patients. This can help improve the patient’s quality of life after treatment and save lives. (Source: NHS Networks)
Source: NHS Networks - August 27, 2013 Category: UK Health Authors: Karen Topping Source Type: news

Conflict-of-Interest Seen in Some Prescribing Radiotherapy for Prostate Cancer (FREE)
By Joe Elia The number of self-referrals for intensity-modulated radiation therapy (IMRT) of prostate cancer has increased in the U.S. in recent years, while use of this treatment has … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - August 20, 2013 Category: Primary Care Source Type: news

GAO report points to prostate cancer IMRT self-referral
A new report published by the U.S. Government Accountability Office (GAO) has (more) (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 2, 2013 Category: Radiology Source Type: news

Seeking A Less Toxic Radiation Treatment For HPV-Positive Oropharynx Cancer
Researchers from Fox Chase Cancer Center and other institutions have completed a phase II clinical trial that may help identify those patients with HPV-positive oropharyngeal cancer who do not require the full radiation dose given in a standard regimen of Intensity-Modulated Radiation Therapy (IMRT). Preliminary findings were presented by Shanthi Marur, first author on the study and an oncologist at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, at the 49th Annual Meeting of the American Society of Clinical Oncology... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 3, 2013 Category: Consumer Health News Tags: Ear, Nose and Throat Source Type: news

Researchers investigate a less toxic radiation treatment for HPV-Positive oropharynx cancer
(Fox Chase Cancer Center) Researchers from Fox Chase Cancer Center and other institutions have completed a phase II clinical trial that may help identify those patients with HPV-positive oropharyngeal cancer who do not require the full radiation dose given in a standard regimen of Intensity-Modulated Radiation Therapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 30, 2013 Category: Global & Universal Source Type: news

IMRT shows rapid uptake but fails to outperform CRT
Intensity-modulated radiotherapy is equivalent to conventional conformal radiotherapy in terms of morbidity and cancer control outcomes in the treatment of prostate cancer after radical prostatectomy, shows a study published in JAMA Internal Medicine. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - May 28, 2013 Category: Cancer & Oncology Source Type: news

IMRT shows rapid uptake but fails to outperform CRT
Intensity-modulated radiotherapy is equivalent to conventional conformal radiotherapy in terms of morbidity and cancer control outcomes in the treatment of prostate cancer after radical prostatectomy, shows a study published in JAMA Internal Medicine. (Source: MedWire News - Prostate Cancer)
Source: MedWire News - Prostate Cancer - May 28, 2013 Category: Cancer & Oncology Source Type: news

IMRT shows rapid uptake but fails to outperform CRT
Intensity-modulated radiotherapy is equivalent to conventional conformal radiotherapy in terms of morbidity and cancer control outcomes in the treatment of prostate cancer after radical prostatectomy, shows a study published in JAMA Internal Medicine. (Source: MedWire News - Urology)
Source: MedWire News - Urology - May 27, 2013 Category: Urology & Nephrology Source Type: news

IMRT Benefits in Prostate Cancer Questioned (CME/CE)
(MedPage Today) -- Men with prostate cancer gained no obvious benefits from treatment with intensity-modulated radiation therapy (IMRT) as compared with an older, less expensive technique, an analysis of a government database suggests. (Source: MedPage Today Urology)
Source: MedPage Today Urology - May 21, 2013 Category: Urology & Nephrology Source Type: news

Two Radiotherapy Treatments Show Similar Morbidity, Cancer Control After Prostatectomy
JAMA Internal Medicine Study Highlights Use of the newer, more expensive intensity-modulated radiotherapy (IMRT) and use of the older conformal radiotherapy (CRT) after surgical removal of all or part of the prostate gland were associated with similar morbidity and cancer control outcomes, according to a study published Online First by JAMA Internal Medicine, a JAMA Network publication. Gregg H. Goldin, M.D... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 20, 2013 Category: Consumer Health News Tags: Prostate / Prostate Cancer Source Type: news

IMRT may not be more effective than older radiation techniques after prostatectomy
(University of North Carolina Health Care) Intensity-modulated radiation therapy has become the most commonly used type of radiation in prostate cancer, but research from the University of North Carolina School of Medicine suggests that the therapy may not be more effective than older, less expensive forms of radiation therapy in patients who have had a prostatectomy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 20, 2013 Category: Global & Universal Source Type: news

IMRT showed fewer adverse effects than standard radiotherapy
(Source: HemOncToday.com)
Source: HemOncToday.com - May 3, 2013 Category: Cancer & Oncology Source Type: news

Intensity Modulated Radiotherapy Reduces Side Effects In Patients With Early Breast Cancer
Intensity modulated radiotherapy (IMRT) gives better results than standard radiotherapy in patients with early breast cancer, according to results from a randomised trial presented today (Sunday) to the 2nd Forum of the European Society for Radiotherapy and Oncology (ESTRO). IMRT is an advanced, high-precision form of radiotherapy that can deliver an even dose of radiation, thus reducing the cosmetic problems that can often occur after breast radiotherapy... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 23, 2013 Category: Consumer Health News Tags: Breast Cancer Source Type: news

In Patients With Early Breast Cancer, Intensity Modulated Radiotherapy Reduces Side Effects
Intensity modulated radiotherapy (IMRT) gives better results than standard radiotherapy in patients with early breast cancer, according to results from a randomised trial presented today (Sunday) to the 2nd Forum of the European Society for Radiotherapy and Oncology (ESTRO). IMRT is an advanced, high-precision form of radiotherapy that can deliver an even dose of radiation, thus reducing the cosmetic problems that can often occur after breast radiotherapy... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 22, 2013 Category: Consumer Health News Tags: Breast Cancer Source Type: news

Intensity modulated radiotherapy reduces side effects in patients with early breast cancer
(European Society for Radiotherapy and Oncology (ESTRO)) Intensity modulated radiotherapy gives better results than standard radiotherapy in patients with early breast cancer, according to results from a randomised trial presented on Sunday to the 2nd Forum of the European Society for Radiotherapy and Oncology. IMRT is an advanced, high-precision form of radiotherapy that can deliver an even dose of radiation, thus reducing the cosmetic problems that can often occur after breast radiotherapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 21, 2013 Category: Global & Universal Source Type: news

Prostate Cancer Treatment Time Shortened By Novel Radiation Therapy Method
According to a study in the Journal of the American College of Radiology, the use of volume-modulated arc therapy (VMAT) to deliver intensity-modulated radiation therapy (IMRT) to prostate cancer patients results in an overall reduction in treatment time of approximately 14 percent. The study was performed at Winship Cancer Institute of Emory University in Atlanta. Treatment with IMRT is increasingly standard for prostate cancer... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 5, 2013 Category: Consumer Health News Tags: Prostate / Prostate Cancer Source Type: news

Novel radiation therapy method shortens prostate cancer treatment time
The use of volume-modulated arc therapy to deliver intensity-modulated radiation therapy to prostate cancer patients results in an overall reduction in treatment time of approximately 14 percent, a new study suggests. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 1, 2013 Category: Science Source Type: news

Novel radiation therapy method shortens prostate cancer treatment time
(American College of Radiology) According to a study in the Jan. issue of the Journal of the American College of Radiology, the use of volume-modulated arc therapy to deliver intensity-modulated radiation therapy to prostate cancer patients results in an overall reduction in treatment time of approximately 14 percent. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 1, 2013 Category: Global & Universal Source Type: news

Proton Therapy Overhyped for Prostate Cancer?Proton Therapy Overhyped for Prostate Cancer?
New studies find that costly proton radiation therapy has no benefit over standard IMRT, so why are some urologists still singing its praises? Dr. Gerald Chodak discusses the issues. Medscape Urology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 30, 2013 Category: Consumer Health News Tags: Urology Commentary Source Type: news

No difference in toxicity observed between proton radiotherapy, IMRT
Yu JB. J Natl Cancer Inst. 2012;doi:10.1093/JNCI/djs639. (Source: HemOncToday.com)
Source: HemOncToday.com - January 14, 2013 Category: Cancer & Oncology Source Type: news

SBRT halves cost vs. IMRT for prostate cancer
As members of Congress grapple over ways to reduce the U.S. budget, the publication (more) (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 3, 2013 Category: Radiology Source Type: news

Summaries: International Kidney Cancer Symposium
Conclusion: there is no increased risk of doing the lymph node dissection early on.   Dr. Eggener-CON   Basics Lymph node dissections rarely done, even for large tumors, because there is no proven therapeutic or staging benefit for low risk patients.  A Mayo study revealed no data showing therapeutic benefit in high risk patients.  For clinically node negative high risk patients, there is staging value but no proven therapeutic benefit. Rate of positive nodes is associated with stage and grade; the higher the stage and grade, the more likely there will be positive nod...
Source: Kidney Cancer Association - November 29, 2011 Category: Urology & Nephrology Source Type: news

Summaries: International Kidney Cancer Symposium
Conclusion: there is no increased risk of doing the lymph node dissection early on. Dr. Eggener-CON  Basics Lymph node dissections rarely done, even for large tumors, because there is no proven therapeutic or staging benefit for low risk patients.  A Mayo study revealed no data showing therapeutic benefit in high risk patients.  For clinically node negative high risk patients, there is staging value but no proven therapeutic benefit. Rate of positive nodes is associated with stage and grade; the higher the stage and grade, the more likely there will be positive nodes.  A tumor> 10 cm w...
Source: Kidney Cancer Association - November 29, 2011 Category: Urology & Nephrology Source Type: news

Siemens 200th PRIMUS Linear Accelerator Will Ship to St. Elizabeth Health Center
The Oncology Care Systems Group of Siemens Medical Systems today announced it is shipping the 200th Siemens PRIMUS -- a medical linear accelerator with the ability to deliver Intensity Modulated Radiation Therapy (IMRT) -- to St. Elizabeth Health Center's new Radiation Oncology Center in Boardman, OH. (Source: Medical Design Online News)
Source: Medical Design Online News - January 1, 1996 Category: Medical Equipment Source Type: news